Fig. 1
From: Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
Source of mesenchymal stem cells (MSCs) and various signalling pathways regulating MSC differentiation. Multiple signalling pathways and cytokines have also been found to be involved in lineage commitment. BMP bone morphogenetic protein, EGF endothelial growth factor, FGF fibroblast growth factor, HGF hepatocyte growth factor, PDGF platelet-derived growth factor, TGF transforming growth factor